Dysregulated PI3K Signaling in B Cells of CVID Patients
The altered wiring of signaling pathways downstream of antigen receptors of T and B cells contributes to the dysregulation of the adaptive immune system, potentially causing immunodeficiency and autoimmunity. In humans, the investigation of such complex systems benefits from nature’s experiments in...
| Published in: | Cells |
|---|---|
| Main Authors: | Ina Harder, Matthias Münchhalfen, Geoffroy Andrieux, Melanie Boerries, Bodo Grimbacher, Hermann Eibel, Maria Elena Maccari, Stephan Ehl, Jürgen Wienands, Julia Jellusova, Klaus Warnatz, Baerbel Keller |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-01-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/11/3/464 |
Similar Items
Current clinical spectrum of common variable immunodeficiency in Spain: The multicentric nationwide GTEM-SEMI-CVID registry
by: Marta Dafne Cabañero-Navalon, et al.
Published: (2022-10-01)
by: Marta Dafne Cabañero-Navalon, et al.
Published: (2022-10-01)
Safety and tolerability of Evusheld in patients with CVID: The Mayo Clinic experience
by: Jacqueline D. Squire, MD, et al.
Published: (2023-05-01)
by: Jacqueline D. Squire, MD, et al.
Published: (2023-05-01)
CD21low B cells reveal a unique glycosylation pattern with hypersialylation and hyperfucosylation
by: Peter Tobias Felixberger, et al.
Published: (2025-02-01)
by: Peter Tobias Felixberger, et al.
Published: (2025-02-01)
mTOR Dysregulation, Insulin Resistance, and Hypertension
by: Silviu Marcel Stanciu, et al.
Published: (2024-08-01)
by: Silviu Marcel Stanciu, et al.
Published: (2024-08-01)
Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID)
by: Remo Poto, et al.
Published: (2023-09-01)
by: Remo Poto, et al.
Published: (2023-09-01)
Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation
by: Roos-Marijn Berbers, et al.
Published: (2025-01-01)
by: Roos-Marijn Berbers, et al.
Published: (2025-01-01)
Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in Common Variable Immunodeficiency (CVID)
by: Nico Hustings, et al.
Published: (2022-12-01)
by: Nico Hustings, et al.
Published: (2022-12-01)
A case report navigating CVID and sarcoidosis overlaps in pediatric nephritis
by: Amanda Salih, et al.
Published: (2024-09-01)
by: Amanda Salih, et al.
Published: (2024-09-01)
Persistent immune activation in CVID and the role of IVIg in its suppression
by: Dominic ePaquin-Proulx, et al.
Published: (2014-12-01)
by: Dominic ePaquin-Proulx, et al.
Published: (2014-12-01)
Bacterial but Not Fungal Gut Microbiota Alterations Are Associated With Common Variable Immunodeficiency (CVID) Phenotype
by: Kristýna Fiedorová, et al.
Published: (2019-08-01)
by: Kristýna Fiedorová, et al.
Published: (2019-08-01)
Interstitial lung diseases (ILD) in common variable immunodeficiency (CVID) patients: a study from Iran
by: Ghamartaj Khanbabaee, et al.
Published: (2024-07-01)
by: Ghamartaj Khanbabaee, et al.
Published: (2024-07-01)
B-2 lymphocytes and the balance of pro and anti-inflammatory cytokines in infectious and autoimmune phenotypes of common variable immune deficiency
by: L. P. Sizyakina, et al.
Published: (2023-12-01)
by: L. P. Sizyakina, et al.
Published: (2023-12-01)
Granulomatous lymphocytic interstitial lung disease in common variable immune deficiency: an in-depth clinical, immunological, functional and radiological exploration with a focus on its management, challenged by chronic CMV infection
by: Mattia Moratti, et al.
Published: (2025-05-01)
by: Mattia Moratti, et al.
Published: (2025-05-01)
Impaired Memory B-Cell Response to Influenza Immunization in Patients With Common Variable Immunodeficiency (CVID)
by: Wei Zhan, et al.
Published: (2021-10-01)
by: Wei Zhan, et al.
Published: (2021-10-01)
Commentary: Gut Antibody Deficiency in a Mouse Model of CVID Results in Spontaneous Development of a Gluten-Sensitive Enteropathy
by: Silje F. Jørgensen, et al.
Published: (2020-08-01)
by: Silje F. Jørgensen, et al.
Published: (2020-08-01)
Inhibition of PIKfyve Leads to Lysosomal Disorders via Dysregulation of mTOR Signaling
by: Jianhong Xia, et al.
Published: (2024-05-01)
by: Jianhong Xia, et al.
Published: (2024-05-01)
Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters
by: Eva Piano Mortari, et al.
Published: (2023-05-01)
by: Eva Piano Mortari, et al.
Published: (2023-05-01)
Dysregulated mTOR networks in experimental sporadic Alzheimer’s disease
by: Suzanne M. de la Monte, et al.
Published: (2024-09-01)
by: Suzanne M. de la Monte, et al.
Published: (2024-09-01)
Overview of Research into mTOR Inhibitors
by: Beibei Mao, et al.
Published: (2022-08-01)
by: Beibei Mao, et al.
Published: (2022-08-01)
Exploring the role of mTOR pathway in aging and age-related disorders
by: Komal Raghuvanshi, et al.
Published: (2025-08-01)
by: Komal Raghuvanshi, et al.
Published: (2025-08-01)
The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma
by: Letizia Todeschini, et al.
Published: (2023-06-01)
by: Letizia Todeschini, et al.
Published: (2023-06-01)
Stalling autophagy: a new function for Listeria phospholipases
by: Ivan Tattoli, et al.
Published: (2014-01-01)
by: Ivan Tattoli, et al.
Published: (2014-01-01)
Modulation of the mTOR Pathway by Curcumin in the Heart of Septic Mice
by: Bruna A. C. Rattis, et al.
Published: (2022-10-01)
by: Bruna A. C. Rattis, et al.
Published: (2022-10-01)
Regulation of mTORC1 by lysosomal calcium and calmodulin
by: Ruo-Jing Li, et al.
Published: (2016-10-01)
by: Ruo-Jing Li, et al.
Published: (2016-10-01)
Electrocardiographic Alterations in Patients with Common Variable Immune Deficiency
by: Yakup Alsancak, et al.
Published: (2020-03-01)
by: Yakup Alsancak, et al.
Published: (2020-03-01)
Targeting mTOR Kinase with Natural Compounds: Potent ATP-Competitive Inhibition Through Enhanced Binding Mechanisms
by: Sulaiman K. Marafie, et al.
Published: (2024-12-01)
by: Sulaiman K. Marafie, et al.
Published: (2024-12-01)
RICTOR Affects Melanoma Tumorigenesis and Its Resistance to Targeted Therapy
by: Ahlem Jebali, et al.
Published: (2021-10-01)
by: Ahlem Jebali, et al.
Published: (2021-10-01)
BVR-A Deficiency Leads to Autophagy Impairment through the Dysregulation of AMPK/mTOR Axis in the Brain—Implications for Neurodegeneration
by: Chiara Lanzillotta, et al.
Published: (2020-07-01)
by: Chiara Lanzillotta, et al.
Published: (2020-07-01)
Dysregulation of Stress-Induced Translational Control by <i>Porphyromonas gingivalis</i> in Host Cells
by: Alex A. Knowles, et al.
Published: (2023-02-01)
by: Alex A. Knowles, et al.
Published: (2023-02-01)
Arginine depletion-induced autophagy and metabolic dysregulation are involved in the disease severity of hand, foot, and mouth disease
by: Yuefei Jin, et al.
Published: (2025-12-01)
by: Yuefei Jin, et al.
Published: (2025-12-01)
Novel Heterozygous Mutation in NFKB2 Is Associated With Early Onset CVID and a Functional Defect in NK Cells Complicated by Disseminated CMV Infection and Severe Nephrotic Syndrome
by: Alejandra Aird, et al.
Published: (2019-07-01)
by: Alejandra Aird, et al.
Published: (2019-07-01)
Autophagy as a Vital Therapy Target for Renal Cell Carcinoma
by: Ying-hua He, et al.
Published: (2021-02-01)
by: Ying-hua He, et al.
Published: (2021-02-01)
Long-term follow-up in common variable immunodeficiency: the pediatric-onset and adult-onset landscape
by: Maria Carrabba, et al.
Published: (2023-04-01)
by: Maria Carrabba, et al.
Published: (2023-04-01)
mTOR-dependent dysregulation of autophagy contributes to the retinal ganglion cell loss in streptozotocin-induced diabetic retinopathy
by: Sanjar Batirovich Madrakhimov, et al.
Published: (2021-02-01)
by: Sanjar Batirovich Madrakhimov, et al.
Published: (2021-02-01)
Dysregulated lipid metabolism in lymphangioleiomyomatosis pathogenesis as a paradigm of chronic lung diseases
by: Clara Bernardelli, et al.
Published: (2023-01-01)
by: Clara Bernardelli, et al.
Published: (2023-01-01)
Dysregulation of mTOR signaling mediates common neurite and migration defects in both idiopathic and 16p11.2 deletion autism neural precursor cells
by: Smrithi Prem, et al.
Published: (2024-03-01)
by: Smrithi Prem, et al.
Published: (2024-03-01)
Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation
by: Vasil Toskov, et al.
Published: (2023-09-01)
by: Vasil Toskov, et al.
Published: (2023-09-01)
Inhibition of insulin/IGF‐1 receptor signaling protects from mitochondria‐mediated kidney failure
by: Christina Ising, et al.
Published: (2015-02-01)
by: Christina Ising, et al.
Published: (2015-02-01)
PRAS40 prevents development of diabetic cardiomyopathy and improves hepatic insulin sensitivity in obesity
by: Mirko Völkers, et al.
Published: (2013-10-01)
by: Mirko Völkers, et al.
Published: (2013-10-01)
New Markers for Cardiovascular Disease in Psoriatic Patients: Preliminary Study on Monocyte Phenotype, ADAMTS7, and mTOR Activity
by: Khanty Loyola, et al.
Published: (2023-01-01)
by: Khanty Loyola, et al.
Published: (2023-01-01)
Similar Items
-
Current clinical spectrum of common variable immunodeficiency in Spain: The multicentric nationwide GTEM-SEMI-CVID registry
by: Marta Dafne Cabañero-Navalon, et al.
Published: (2022-10-01) -
Safety and tolerability of Evusheld in patients with CVID: The Mayo Clinic experience
by: Jacqueline D. Squire, MD, et al.
Published: (2023-05-01) -
CD21low B cells reveal a unique glycosylation pattern with hypersialylation and hyperfucosylation
by: Peter Tobias Felixberger, et al.
Published: (2025-02-01) -
mTOR Dysregulation, Insulin Resistance, and Hypertension
by: Silviu Marcel Stanciu, et al.
Published: (2024-08-01) -
Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID)
by: Remo Poto, et al.
Published: (2023-09-01)
